Pharmacologic or genetic inhibition of IRAK1 induced cell cycle arrest and apoptosis in MDS cells and improved survival in an MDS xenograft model (56), suggesting that IRAK1 may be a potential therapeutic target in MDS. The gene discussed is IRAK1; the disease is myelodysplastic syndrome.